Premium
Influence of lipid solubility on the sperm immobilizing effect of beta‐ adrenoceptor blocking drugs.
Author(s) -
Hong CY,
Turner P
Publication year - 1982
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/j.1365-2125.1982.tb01972.x
Subject(s) - beta adrenoceptor , pharmacology , blocking (statistics) , chemistry , beta (programming language) , solubility , adrenergic receptor , adrenergic beta antagonists , medicine , endocrinology , receptor , propranolol , computer science , programming language , statistics , mathematics , organic chemistry
1 Sperm immobilizing effects of five beta‐adrenoceptor blockers were measured on six human semen samples with a trans‐membrane migration method. 2 The concentrations which decreased sperm motility to 50% of control (ED50) were 0.8, 4.2, 6.2, 11.0 and 33.0 mM for propranolol, oxprenolol, metoprolol, acebutolol and sotalol respectively. 3 There was a linear correlation between the log values of ED50 and the log partition coefficients of these beta‐adrenoceptor blockers. 4 Because the lipid solubility determines the sperm immobilizing potencies of beta‐adrenoceptor blockers, we support the theory that beta‐ adrenoceptor blockers inhibit sperm motility by stabilizing the cellular membrane. 5 The clinical implication of this finding is that more lipid soluble drugs are likely to have more interference on sperm function, at least when they are used locally.